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Summary To elucidate the roles of enteric bacteria and immunological interactions among
liver, spleen and intestine in the pathogenesis of liver injury during obstructive jaundice, we
studied the effects of antibiotics and splenectomy on bile-duct-ligated C57BL mice. When
animals were subjected to bile-duct-ligation (BDL), plasma levels of bilirubin, alanine
aminotransferase and aspartate aminotransferase increased markedly. However, the increases
in plasma transaminases were significantly lower in splenectomized or antibiotics-treated
groups than in the control BDL group. Histological examination revealed that liver injury was
also low in the two groups. BDL markedly increased plasma level of interferon-γ (IFN-γ) and
the expression of inducible nitric oxide synthase (iNOS) in liver and spleen. These changes
were suppressed either by splenectomy or administration of antibiotics. Kinetic analysis
revealed that BDL-induced liver injury and the increase of interleukin-10 (IL-10) and INF-γ
were lower in iNOS−/− than in wild type animals. BDL markedly increased the expression of
IgA in colonic mucosa. These observations suggest that enteric bacteria, nitric oxide and
cytokines including IFN-γ and IL-10 derived from spleen and intestines form a critical
network that determines the extent of liver injury during obstructive jaundice.
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Introduction
The obstruction of the bile duct often occurs in various
diseases including impaction of gallstones or hepato-cholangial
and pancreatic tumors [1]. The biliary obstruction causes
cholestatic liver injury, hepatocellular necrosis, proliferation
of bile ductular epithelial cells, and activation of stellate
cells followed by liver fibrosis [2, 3]. During cholestatic
liver injury, both the hepatic expression of inducible nitric
oxide synthase (iNOS) and the blood level of endotoxin
markedly increase [4,  5]. Hepatocytes, macrophages and
lymphocytes have been shown to express iNOS following
the stimulation by viral and bacterial infections [6–8]. The
expression of iNOS in rodents and humans is enhanced
by various factors such as endotoxin and inflammatory
cytokines [9–13]. Nitric oxide generated by iNOS plays two
opposite roles. While it protects the liver and other tissues,
it could also cause impairments of these tissues [14–19].
However, the roles of nitric oxide (NO) and extrahepatic
tissues in liver injury during obstructive jaundice remain
unclear. The impairment of bile secretion into the intestine
enhances the translocation of bacteria across the intestinal
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mucosa and sometimes causes lethal endotoxemia during
obstructive jaundice [20, 21]. Although the spleen produces
various cytokines and plays important roles in host defense
mechanism against pathogens, its roles in the etiology of liver
injury during obstructive jaundice are not well understood.
In order to elucidate the roles of enteric bacteria, iNOS-
derived NO and the spleen in the pathogenesis of liver injury
in obstructive jaundice, we undertook this project to study
the effects of bile-duct-ligation (BDL), antibiotics, and
splenectomy on liver functions of wild and iNOS−/− mice.
Materials and Methods
Reagents
Assay Kits for the determination of aspartate amino-
transferase (AST), alanine aminotransferase (ALT), bilirubin,
and lipopolysaccharide (LPS) in the plasma were obtained
from Wako Pure Chemical Co. (Osaka, Japan). Penicillin G
potassium and streptomycin sulfate were obtained from
Meiji Seika, LTD (Tokyo, Japan). Mouse monoclonal antibody
against iNOS (610432), rabbit anti-iNOS polyclonal anti-
body (KAS-NO001), and goat anti-mouse immunoglobulin
A (IgA) (62-6700) were obtained from BD Transduction
Laboratories (San Jose, CA), Stressgen Biotechnologies
(Victoria, Canada), and from Zymed Laboratories (San
Francisco, CA), respectively. ELISA Kits for mouse interferon-
γ (IFN-γ) and interleukin-10 (IL-10) were obtained from
PIERCE ENDOGEN (Rockford, IL). Other reagents used
were of the highest grade commercially available.
Animal experiments
Male C57BL/6J mice (20–25 g) and their iNOS−/− strain
were purchased from SLC (Shizuoka, Japan) and Jackson
Laboratories (Coldspring Habor, MA), respectively. Animals
were allowed free access to laboratory chow (CE-2, Oriental
Yeast Co., Tokyo, Japan) and water ad libitum during the
experiments. All experiments were approved by the Animal
Care and Use Committee of Osaka City University Medical
School. Obstructive jaundice was elicited by ligating the
common bile duct (BDL) as described previously [22].
Under light ether anesthesia, animals (80 animals/group)
were subjected to BDL. In some animals, streptomycin
(4 mg/ml) and penicillin G (2 mg/ml) were added in the
drinking water during the experiments from one week before
giving BDL. Another group of animals received both BDL
and splenectomy. Sham-operation was performed as the
control experiments. At the indicated times after giving
BDL, animals were sacrificed to obtain blood and liver
specimens for biochemical and histological analyses.
Biochemical analysis
The blood samples from BDL mice were diluted in 9
volumes of 3.8% sodium citrate and used for blood cell
counting and chemiluminescence analysis. For cell counting,
50 µl of the blood samples were used for the analysis using
a Celltac α (Nihon Koden MEK-6258, Tokyo, Japan). In
chemiluminescence analysis, the blood samples (50 µl) were
incubated in 0.5 ml of phosphate-buffered saline (PBS)
containing 400 µM L-012, a highly sensitive chemilumi-
nescence probe [23]. After incubation of the mixtures at
37°C for 3 min, the reaction was started by adding
opsonized zymosan (5 mg/ml). During the incubation,
chemiluminescence intensity was recorded continuously for
10 min using a Luminescence Reader BLR-201 (Aloka,
Tokyo, Japan). Plasma levels of AST, ALT, total bilirubin,
LPS, IFN-γ, and IL-10 were determined according to the
manufacturer’s instructions.
Histological analysis
The liver specimens were fixed in phosphate-buffered
formalin (10%), embedded in paraffin, and cut into 4-µm-
thick sections. Thin sections were stained with hematoxylin-
eosin and analyzed histologically to evaluate the degree of
liver injury caused by BDL. The expression of iNOS was
evaluated immunohistochemically under a fluorescent micro-
scope as described previously [12]. Colon specimens were
rapidly frozen in an OCT embedding medium (Tissue-Tek,
Elkhart, IN) and stored at −80°C until use. Cryostat sections
(6 µm thickness) were fixed in ice-cold acetone for 10 min.
The expression of IgA was evaluated immunohistochemically
under a fluorescent microscope as described previously [24].
Western blot analysis
The liver was homogenized in a lysis buffer containing
0.5% Nonidet P-40, 10% glycerol, 137 mM NaCl, 2 mM
ethylendiamine-tetraacetic acid, and 50 mM Tris-HCl buffer
(pH 8.0). After centrifugation at 3,000 × g for 10 min, the
supernatant was separated and stored at −80°C. The stored
specimens were subjected to 7.5% polyacrylamide gel electro-
phoresis (PAGE) in the presence of 0.1% SDS. The electro-
phoresed proteins in the gel were transferred to an Immobilon
membrane (Millipore, Bedford, MA). The membrane was
blocked with 5% skim milk at 4°C for overnight, subsequently
incubated with primary antibodies at 25°C for 1 h and then
with horseradish peroxidase-conjugated secondary anti-
bodies. Immune complexes thus formed were detected
with ECL reagents reagents (GE Healthcare Bio-Sciences,
Piscataway, NJ).
Statistical analysis
All data were expressed as the mean ± SD. The results
obtained from the four animal groups were analyzed by
either Student’s t test or ANOVA using a computer software.
Differences were considered significant when p<0.05.J.-Y. Hong et al.
J. Clin. Biochem. Nutr.
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Results
Roles of enteric bacteria and the spleen in BDL-induced
liver injury
Since the obstruction of the bile duct impairs the secretion
of the bile juice into the intestinal lumen, it decreases the
bile-dependent intestinal functions, such as digestion of
lipophilic nutrients and regulation of intestinal flora, and
results in the regurgitation of hazardous bile acids and a
variety of biliary metabolites. High concentrations of these
metabolites often cause injury to the liver and other organs.
To evaluate the effect of regurgitation of bile constituents on
liver functions, changes in plasma levels of bilirubin and
transaminases were determined after BDL. BDL increased
the plasma levels of bilirubin in a time-dependent manner in
control and iNOS−/− mice (Fig. 1). Although bilirubin levels
also increased similarly in BDL-animals pretreated with
antibiotics, splenectomy suppressed the rate of its increase.
Despite the continuous increase of bilirubin levels in control
animals, BDL increased the plasma levels of AST and ALT
in a biphasic manner (the first peak followed by the second
peak). Interestingly, BDL-induced increase in transaminases
was significantly low in animals that had been received either
antibiotics or splenectomy. The BDL-induced increases in
transaminases occurred relatively slowly in iNOS−/− mice,
peaked on day 3, and decreased thereafter. Thus, the area
under the curve for the transaminases was slightly but
significantly smaller in iNOS−/− than in control mice. BDL
slightly decreased the survival rate of animals on day 5 and
6. Interestingly, the survival rate was significantly higher
in iNOS−/− mice and splenectomized animals. In contrast,
animals treated with antibiotics died within 7 days at the
time when other BDL groups remain survived.
Since the spleen is responsible for the elimination of
injured blood cells including erythrocytes, splenectomy may
affect the profiles of blood cells in the circulation. To test this
possibility, we analyzed the profiles of the circulating blood
cells after splenectomy and/or BDL. However, populations
of blood cells including platelets remained unchanged
during the experiments (Fig. 2).
Histological examination revealed that BDL rapidly
induced liver injury in the control group (Fig. 3). Consistent
with the difference in the increase of plasma transaminases,
liver injury was less apparent with animals that had been
received either antibiotics or splenectomy. Liver injury was
also mild in iNOS−/− mice as compared to control BDL
Fig. 1.  Effect of BDL on plasma bilirubin, transaminases, and survival rate. Under light ether anesthesia, animals were subjected to
bile-duct-ligation (BDL). At the indicated times after BDL, plasma levels of total-bilirubin (A), AST (B), and ALT (C), were
measured as described in the text. During the experiment, survival rate of animals was analyzed (D). Open circles: control mice
(BDL alone); Open squares, animals pretreated with antibiotics from 1 week before BDL (Abx); Closed squares, animals
splenectomized just before BDL (Spx); Closed circles, iNOS−/− mice which received BDL (iNOS−/−). Crosses, sham-operated
mice. Statistical difference between control (BDL alone) and experimental groups is analyzed by Student’s t test. *p<0.05The Pathogenesis of Obstructive Liver Injury
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Fig. 2.  Effect of splenectomy on the population of the circulating blood cells. At the indicated times after BDL, blood samples were
obtained. The population of blood cells was analyzed as described in the text. Open circles, control mice (BDL alone); Closed
squares, animals splenectomized just before BDL (Spx); Open triangle, splenectomized animals without BDL (Spx-only);
Crosses, sham-operated mice.
Fig. 3.  Histological examination of liver specimens after BDL. At the indicated times after BDL, the liver specimens were obtained,
fixed with 10% formalin, and embedded in paraffin. Thin sections of the liver specimens were stained with hematoxylin-eosin
(A). Area of necrosis was determined by using a Image J Software and expressed as % of total area (B). Statistical difference
between control (BDL alone) and experimental groups is analyzed by Student’s t test. *p<0.05. All symbols and other conditions
were as in Fig. 1. Scale bar = 100 µm.J.-Y. Hong et al.
J. Clin. Biochem. Nutr.
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animals. These observations suggest that the intestinal flora,
iNOS-derived NO and the immune system in the spleen play
critical roles in the determination of obstructive liver injury.
BDL increased the plasma level of endotoxin
Since bile acids have a detergent-like activity and function
as bacteriostatic compounds, lack of bile juice may affect
enteric flora and increase the incidence of bacterial trans-
location across the intestinal mucosa [20, 21]. To test this
possibility, we measured the plasma levels of endotoxin
before and after BDL (Fig. 4). As expected, the plasma level
of endotoxin in control mice increased after BDL, peaked on
day 5 and decreased thereafter. The level of endotoxin in
animals administered with antibiotics was below detectable
levels during the experiments. Although splenectomy did
not affect the BDL-induced increase in plasma endotoxin,
the extent of the increase was significantly high with iNOS−/−
mice. The marked increase in plasma endotoxin in iNOS−/−
mice was strongly inhibited by antibiotics. These observations
suggest that BDL changed the enteric flora and enhanced
bacterial translocation across the intestinal mucosa by a
mechanism that was suppressed by antibiotics and iNOS-
derived NO.
BDL increased plasma levels of cytokines
Since endotoxin stimulates a variety of leucocytes via the
receptor-mediated mechanism, we determined the changes
in plasma levels of cytokines. The plasma level of IL-10
rapidly increased after BDL, peaked on day 1 and decreased
thereafter. Although the BDL-induced increase in plasma IL-
10 remained unaffected by antibiotics, it increased markedly in
splenectomized animals (Fig. 5). As shown in the two columns
under the sign of “BDL”, the BDL-induced increase in
plasma IL-10 was lower in iNOS−/− mice than in control mice.
Splenectomy performed right before BDL (+Splenectomy)
enhanced the BDL-induced increases of IL-10 remarkably
on day 1 in both animal groups. The plasma level of IFN-γ
increased after BDL, peaked on day 5 and decreased
thereafter. In the antibiotics-treated group and the iNOS−/−
group, the BDL-induced increase in IFN-γ occurred slightly
faster. It peaked on day 3 and decreased thereafter. The
BDL-induced increase in IFN-γ was slightly smaller with
iNOS−/− mice than with the control group. Splenectomy
markedly inhibited the BDL-induced increase in plasma
IFN-γ.
BDL induced the expression of IgA in the intestine
Changes in intestinal flora have been known to modulate
mucosal lymphocytes that secrete Th2-type cytokines and
antibodies, such as IL-10 and IgA, respectively [25]. Thus,
we analyzed the expression of IgA in the colon from
BDL-treated animals. Colonic expression of IgA markedly
increased after BDL. As shown in Fig. 6, the expression of
IgA in the control group increased after BDL, peaked on day
3, and decreased thereafter. However, the expression of IgA
in animals pretreated with antibiotics was extremely low. The
expression in splenectomized-BDL mice peaked on day 1,
but it decreased thereafter. A possible relationship between
the IgA peak at day 1 and an extremely high level of IL-10
in splenectomized-BDL wild mice (Fig. 5B) will be discussed
in the Discussion section. Although the expression of IgA
was low in iNOS−/− mice during the first 3 days, it increased
significantly 5 days after BDL.
BDL induced ROS generation from circulating neutrophils
Since the BDL-induced cytokines have potent activities to
stimulate leucocytes and modulate their metabolism, we
analyzed the activity of circulating neutrophils in generating
reactive oxygen species (ROS) using L-012-dependent
chemiluminescence. The ROS generation by neutrophils in
the blood increased after BDL, peaked on day 5 and
decreased thereafter (Fig. 7). It decreased slightly in mice
treated with antibiotics and greatly in splenectomized
animals. In iNOS−/− mice, it peaked on day 3, and the peak
value was lower than that in control animals.
BDL induced expression of iNOS in the liver
Since BDL caused significant differences between wild mice
and iNOS−/− mice in terms of the plasma levels of endotoxin
and cytokines as well as the degree of liver injury, we
Fig. 4.  Effect of BDL on plasma level of endotoxin. The plasma
level of endotoxin was measured as described in the text.
Open circles: control mice (BDL alone); Open squares,
animals pretreated with antibiotics from 1 week before
BDL; Closed squares, animals splenectomized just before
BDL; Closed circles, iNOS−/− mice which received BDL.
Open triangles, iNOS−/− mice treated with antibiotics 1
week before BDL Cross: sham-operated mice. Statistical
analysis carried out as in Fig. 1. *p<0.05The Pathogenesis of Obstructive Liver Injury
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Fig. 5.  Effect of BDL on plasma level of cytokines. Plasma levels of IL-10 (A and B) and INF-γ (C) were measured after BDL as
described in the text. In panel B, the plasma levels of IL-10 in BDL mice (left two columns) and splenectomized-BDL wild
mice and iNOS−/− mice (right two columns) are also shown. All symbols are the same as those in Fig. 1. All values are shown as
the mean ± SD. Statistical analysis carried out as in Fig. 1. *p<0.05
Fig. 6.  Histological examination of the expression of IgA in the colon. At the indicated times after BDL, colon specimens were frozen,
cut into thin sections, treated with anti-IgA antibody and then stained with FITC-conjugated second antibody. Other conditions
were the same as in Fig. 1. Scale bar = 50 µm.J.-Y. Hong et al.
J. Clin. Biochem. Nutr.
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analyzed the expression of iNOS in liver specimens from
BDL-treated wild mice and iNOS−/− mice (Fig. 8). Immuno-
histochemical and Western blotting analysis revealed that
BDL markedly induced iNOS in the liver of wild mice. The
expression increased with time, peaked on day 3 and
decreased thereafter. The BDL-induced expression of iNOS
was inhibited significantly in animals pretreated with anti-
biotics and completely in splenectomized animals. Naturally,
no iNOS was induced by BDL in the knockout mice.
Discussion
The present work shows that obstruction of the bile duct
impaired the liver in a biphasic manner by a mechanism that
was inhibited strongly by splenectomy and mildly by the
administration of antibiotics. It has been well documented
that a high concentration of bile acids has a detergent-like
activity and exerts toxic effects on biological membranes
[26–28]. Thus, the initial increase of plasma transaminases
(Fig. 1) seems to reflect the toxic effects of the regurgitated
bile acids to the liver. Although hyperbilirubinemia has been
used for a long time as a marker for heme degradation and/
or disturbance of biliary elimination pathway, conjugated
bilirubin is no-toxic antioxidant to suppress oxidative stress
[29]. It should be noted that conjugated bilirubin is pre-
dominantly responsible for the hyperbilirubinemia induced
by BDL [30]. Thus, it is not surprising that plasma bilirubin
level increased fairly slowly while plasma transaminases, a
marker for necrotic injury of hepatocytes, increased rapidly
in a biphasic manner.
The increase in AST on day 1 was about three-fold higher
than that of ALT, suggesting an occurrence of mild hemolysis
in BDL-mice. Since the spleen eliminates injured erythrocytes
from the circulation, this organ might be responsible for the
hemolysis during the early period of obstructive jaundice.
Consistent with this notion is the findings that splenectomy
markedly inhibited the BDL-induced increase in plasma
levels of transaminases and bilirubin. Since the population
of blood cells including erythrocytes remained unchanged
after splenectmy in all animal groups, the spleen might
induce minimum hemolysis without affecting cell kinetics of
leukocytes and platelets in the circulation (Fig. 2).
High concentrations of bile acids have been known to
exhibit bacteriostatic activity [31,  32]. Administration of
antibiotics has been shown to decrease the number of enteric
bacteria [33, 34]. Light microscopic examination revealed that,
under the present experimental conditions, the administration
of antibiotics for 1 week decreased the number of enteric
bacteria to less than 0.0001% of the initial level (data not
shown). A lack of bile secretion caused by obstructive jaundice
enhanced bacterial translocation across the intestinal mucosa
[20, 21]. In fact, the pretreatment of animals with antibiotics
completely inhibited the BDL-induced elevation of endotoxin
in the plasma (Fig. 4). Since the administration of antibiotics
significantly suppressed the BDL-induced increase of plasma
transaminases, changes in the intestinal flora would also
participate in the modulation of liver injury during obstructive
jaundice. It should be noted that the intestinal mucosa is
one of the major sites for the immunological defense
against pathogens. Hence, mucosal tissues are highly
enriched with dendritic cells for the recognition of antigens
and with lymphocytes for the elimination of pathogens. The
administration of antibiotics seems to affect the status of
intestinal flora and, hence, they may modulate the mucosal
immune reactions. All of these factors seem to underlie the
mechanism by which antibiotics significantly inhibited the
BDL-induced liver injury (Figs. 1 and 3).
In the control (BDL alone) mice, the bilirubin level peaked
on day 5. The transaminase levels had two peaks, namely,
on day 1 and day 5. On day 5, we observed that the ROS
generation by circulating neutrophils also increased markedly
by a mechanism that was inhibitable by splenectomy. The
histological examination demonstrated that necrosis was
markedly enhanced in the liver by a mechanism that could be
significantly inhibited by splenectomy and by antibiotics. Thus,
the initial phase of BDL-induced liver injury on day 1 seems
to elicit long-lasting inflammatory reactions through day 2
Fig. 7.  Effect of BDL on ROS generation by circulating neutro-
phils. At the indicated times after BDL, 0.5 ml of blood
samples were obtained from mice in 50 µl of 3.8% sodium
citrate. The blood samples (50 µl) were incubated in
0.5 ml of phosphate-buffered saline in the presence of
400 µM L-012. After incubation of the mixture for 3 min
at 37°C, the reaction was started by adding 5 µg/ml of
opsonized zymosan. All symbols are the same as those
in Fig. 1. Statistical analysis carried out as in Fig. 1.
*p<0.05The Pathogenesis of Obstructive Liver Injury
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to day 5 and activated immunocytes in the spleen and other
tissues to regulate the generations of ROS, NO and various
cytokines including IFN-γ. This hypothesis is consistent
with our findings that splenectomy strongly inhibited (i) the
BDL-induced increase in ROS generation by the circulating
neutrophils (Fig. 7), (ii) the elevation of plasma IFN-γ
(Fig. 5) and (iii) the enhancement of the expression of
hepatic iNOS (Fig. 8). All of these effects seem to be the
causes for the observed suppression of liver injury.
The present work demonstrates that splenectomy enhanced
the BDL-induced increase of IL-10, an anti-inflammatory
cytokine (Fig. 5). Th1- and Th2-type lymphocytes cross-talk
with each other to regulate a sequence of inflammatory
reactions to favor the survival of animals [35, 36]. Since the
plasma level of IL-10 markedly increased on day 1 by a
mechanism that was inhibited by splenectomy, Th2-type
lymphocytes in extrasplenic tissue(s) might be activated
during the initial period of obstructive jaundice. It has been
known that Th2-type lymphocytes and plasma cells in the
intestinal mucosa secrete IL-10 and IgA, respectively [25].
We also found that BDL markedly increased the mucosal
expression of IgA in the colon by a mechanism that was
suppressed by antibiotics (Fig. 6). These observations
suggest that a lack of bile juice changed the intestinal flora,
thereby stimulating Th2-type lymphocytes in the intestinal
mucosa to produce IL-10 and subsequently increase IgA
secretion. IFN-γ derived from the activated splenocytes
seems to suppress the intestinal secretion of IL-10 from Th2-
type lymphocytes and maintain the inflammatory reactions
in the liver, particularly during an early period of obstructive
Fig. 8.  Effect of BDL on hepatic expression of iNOS. At the indicated times after BDL, liver specimens were incubated with anti-iNOS
antibody and then stained with FITC-conjugated second antibody (A). Expression of iNOS was determined by Western blot
analysis (B). Equal amounts of protein (30 µg/lane) were subjected to a 7.5% SDS-PAGE, and the electrophoresed proteins
were transferred onto Immobilon-P membranes, and analyzed using specific anti-iNOS antibody. The bands with 130 kDa
responsible for iNOS were seen in liver specimens from BDL mice. Data show one typical result out of 3 representative
experiments. Scale bar = 100 µm.J.-Y. Hong et al.
J. Clin. Biochem. Nutr.
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jaundice.
Endotoxin activates Kupffer cells and a variety of immuno-
cytes to stimulate cytokine production and iNOS expression
in the liver and other tissues [13]. Although BDL increased
endotoxin levels in plasma more markedly with iNOS−/− mice
than with wild-type animals, the liver injury was relatively
mild with the former as compared with the latter (Fig. 4).
The BDL-induced elevation of IFN-γ and IL-10 was also
lower with iNOS−/− mice than with wild-type mice. Although
iNOS-derived NO play a role in the regulation of ROS and
cytokines, the elevation of plasma endotoxin per se may not
be essential for the deterioration of BDL-induced liver injury.
The present work also revealed that the pretreatment of
animals with antibiotics suppressed both the BDL-enhanced
expression of iNOS in the liver and ROS generation by the
circulating neutrophils. However, all animals treated with
antibiotics died within 7 days at the time when other BDL
groups survived. In rodents, the antibiotics used for the
present experiments are excreted predominantly by the liver
through organic anion transport systems [37]. Although the
kidney also excretes these antibiotics particularly when
hepatic excretion is decreased, a hepato-renal syndrome
induced by liver injury and hyperbilirubinemia might inhibit
renal functions to excrete xenobiotics [30]. In fact, bio-
chemical analysis revealed that plasma levels of BUN
(10–14 mg/dl in intact animals) increased rapidly after BDL
and peaked on day 3 (40–50 mg/dl) both in control and
antibiotics-treated groups. Thus, BDL might also inhibit the
excretory systems for antibiotics in the kidney, thereby
enhancing the retention of antibiotics to exhibit the toxic
effects of the drugs to increase the mortality of animals. The
mechanism by which antibiotics increased the mortality of
BDL animals should be studied further.
In summary, our observations suggest that obstructive
liver injury is enhanced by INFγ-dependent splenic response
to bacteria and iNOS-derived NO, but suppressed by IL-10
generated by intestinal mucosal lymphocytes. Thus, immuno-
logical cooperation and cross-talk among the intestine, liver,
spleen and kidney, and the use of antibiotics play critical
roles in the determination of clinical course of patients with
obstructive jaundice.
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